Aurinia Pharmaceuticals (AUPH) Cash from Operations (2020 - 2026)
Aurinia Pharmaceuticals (AUPH) posted Cash from Operations of 32560000.0 for Q1 2026, down 28.7% on a QoQ basis from 45668000.0 in Q4 2025, and up 2404.62% year-over-year from 1300000.0 in Q1 2025.
Aurinia Pharmaceuticals (AUPH) Cash from Operations (2020 - 2026) Analysis & Trends
Aurinia Pharmaceuticals' Cash from Operations history runs 7 years deep, the most recent figure standing at 32560000.0 for Q1 2026.
- Quarterly Cash from Operations rose 2404.62% year-over-year to 32560000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 166918000.0 (up 159.65% YoY) and the FY2025 annual result came in at 135658000.0, up 205.62% from the prior year.
- Cash from Operations was 32560000.0 for Q1 2026 at Aurinia Pharmaceuticals, down from 45668000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 45668000.0 in Q4 2025 and bottomed at 46746000.0 in Q1 2022.
- A 5-year average of 5859764.71 and a median of 10450000.0 in 2022 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2022 — Cash from Operations rose 12.69% — and 2026, when it soared 2404.62%.
- Aurinia Pharmaceuticals' Cash from Operations stood at 10450000.0 in 2022, then surged by 36.96% to 14312000.0 in 2023, then jumped by 110.41% to 30114000.0 in 2024, then soared by 51.65% to 45668000.0 in 2025, then dropped by 28.7% to 32560000.0 in 2026.
- Business Quant data shows AUPH's Cash from Operations at 32560000.0 in Q1 2026, 45668000.0 in Q4 2025, and 44449000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Aurinia Pharmaceuticals | 2.02 Bn | 1.64 Bn | 71.20 Mn | 32.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.56 Mn |
| Mar 31, 2026 | 32.56 Mn |
| Dec 31, 2025 | 45.67 Mn |
| Dec 31, 2025 | 45.67 Mn |
| Sep 30, 2025 | 44.45 Mn |
| Sep 30, 2025 | 44.45 Mn |
| Jun 30, 2025 | 44.24 Mn |
| Jun 30, 2025 | 44.24 Mn |
| Mar 31, 2025 | 1.30 Mn |
| Mar 31, 2025 | 1.30 Mn |
| Dec 31, 2024 | 30.11 Mn |
| Dec 31, 2024 | 30.11 Mn |
| Sep 30, 2024 | 17.03 Mn |
| Sep 30, 2024 | 17.03 Mn |
| Jun 30, 2024 | 15.84 Mn |
| Jun 30, 2024 | 15.84 Mn |
| Mar 31, 2024 | -18.60 Mn |
| Mar 31, 2024 | -18.60 Mn |
| Dec 31, 2023 | 14.31 Mn |
| Dec 31, 2023 | 14.31 Mn |